Bank of America Securities: Cuts the target price of JuZiShengSheng Biotechnology (02367.HK) to 55.5 Hong Kong dollars and reaffirms a "buy" rating.

According to the Zhongtong Financial APP, Bank of America Securities released a research report stating that it has lowered its revenue forecast for Junshi Biosciences (02367.HK) for the years 2025 to 2027 by 21%, 24%, and 25%, and lowered its net profit forecast by 21%, 24%, and 24% respectively. The target price has been reduced from 68.3 Hong Kong dollars to 55.5 Hong Kong dollars, but they reiterated a "buy" rating because they believe that the newly approved injectable medical beauty products are expected to become the company's new growth engine next year.